The Patent Finder

Terms ending in 2033

Yeda Research and Development Co. Ltd.

Every in-force patent on Yeda Research and Development Co. Ltd.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,410,131Enzymatic Systems for Carbon Fixation and Methods of Generating Same
In force
 · High confidence
Yeda Research and Development Co. Ltd.In forceHigh confidence
US 9,290,441Use of Ruthenium Complexes for Formation And/Or Hydrogenation of Amides and Related Carboxylic Acid Derivatives
In force
 · High confidence
Yeda Research and Development Co. Ltd.In forceHigh confidence
US 9,387,264Reporter Genes for Magnetic Resonance Imaging and Methods of Use Thereof
In force
 · High confidence
The National Institute for Biotechnology in the NegevIn forceHigh confidence
US 10,426,821Variants of Tace Pro-Domain as Tnf-A Inhibitor and Their Medical Use
In force
 · Medium confidence
Yeda Research and Development Co. Ltd.In forceMedium confidence
US 10,933,122Variants of Tace Pro-Domain as Tnf-A Inhibitor and Their Medical Use
In force
 · Medium confidence
Yeda Research and Development Co. Ltd.In forceMedium confidence
US 9,771,832Method for Modifying a Solar Thermal Power Plant Operating on Conventional Oil Based Technology into a Hybrid Solar Thermal Power Plant and Such a Hybrid Solar Thermal Power Plant
In force
 · High confidence
Stamicarbon B.V. Acting Under the Name of MT Innovation Center, Enea - Casaccia Research Centre and Yeda Research and Development Co., Ltd.In forceHigh confidence
US 9,492,514Ceramide Levels in the Treatment and Prevention of Infections
In force
 · High confidence
Icahn School of Medicine at Mount SinaiIn forceHigh confidence
US 10,159,724Ceramide Levels in the Treatment and Prevention of Infections
In force
 · High confidence
Icahn School of Medicine at Mount SinaiIn forceHigh confidence
US 11,497,776Combination Therapy for a Stable and Long Term Engraftment
In force
 · High confidence
Yeda Research and Development Co. Ltd.In forceHigh confidence
US 11,504,399Combination Therapy for a Stable and Long Term Engraftment Using Specific Protocols for T/B Cell Depletion
In force
 · High confidence
Yeda Research and Development Co. Ltd.In forceHigh confidence
8 more term ends in 2033 · Pro
10 of 18 patents shown. Soonest term end first, then patent number.
Pro members see all 18.
Upgrade to Pro
16 of these are in force and held by Yeda Research and Development Co. Ltd..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited